First Header Logo Second Header Logo

Connection

Nancy Kock to Enzyme-Linked Immunosorbent Assay

This is a "connection" page, showing publications Nancy Kock has written about Enzyme-Linked Immunosorbent Assay.
Connection Strength

0.120
  1. Holbrook BC, Kim JR, Blevins LK, Jorgensen MJ, Kock ND, D'Agostino RB, Aycock ST, Hadimani MB, King SB, Parks GD, Alexander-Miller MA. A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model. J Immunol. 2016 07 15; 197(2):555-64.
    View in: PubMed
    Score: 0.033
  2. Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Virology. 2011 Oct 25; 419(2):97-106.
    View in: PubMed
    Score: 0.024
  3. Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R, Torti FM, Torti SV. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials. 2011 Sep; 32(26):5970-8.
    View in: PubMed
    Score: 0.023
  4. Sukumar N, Sloan GP, Conover MS, Love CF, Mattoo S, Kock ND, Deora R. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines. Infect Immun. 2010 May; 78(5):2008-16.
    View in: PubMed
    Score: 0.021
  5. Capraro GA, Johnson JB, Kock ND, Parks GD. Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5. Virology. 2008 Jul 05; 376(2):416-28.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.